Table 4 Treatment characteristics of patients infected with COVID-19

Remdesivir

Yes

476 (44.8%)

335 (70.4%)

141 (29.6%)

 < 0.001^‡

Favipiravir

Yes

572 (53.8%)

366 (64.0%)

206 (36.0%)

 < 0.001^‡

Hydroxychloroquine

Yes

241 (22.7%)

118 (49.0%)

123 (51.0%)

0.022^‡

Heparin

Yes

171 (16.1%)

58 (33.9%)

113 (66.1%)

 < 0.001^‡

Atrovent

Yes

50 (4.7%)

21 (42.0%)

29 (58.0%)

0.051^‡

Insulin

Yes

109 (10.3%)

19 (17.4%)

90 (82.6%)

 < 0.001^‡

Diuretic

Yes

95 (8.9%)

57 (60.0%)

38 (40.0%)

0.346^‡

Antifungal

Yes

251 (23.6%)

26 (10.4%)

225 (89.6%)

 < 0.001^‡

Corticosteroid

Yes

933 (87.8%)

517 (55.4%)

416 (44.6%)

0.995^‡

IVIg

Yes

77 (7.2%)

39 (50.6%)

38 (49.4%)

0.383^‡

NSAIDs

Yes

815 (76.7%)

450 (55.2%)

365 (44.8%)

0.817^‡

ACEi

Yes

128 (12.0%)

28 (21.9%)

100 (78.1%)

 < 0.001^‡

ARB

Yes

37 (3.5%)

6 (16.2%)

31 (83.8%)

 < 0.001^‡

Vitamin C

Yes

294 (27.7%)

174 (59.2%)

120 (40.8%)

0.126^‡

Vitamin D

Yes

431 (40.5%)

236 (54.8%)

195 (45.2%)

0.724^‡

Vitamin Zn

Yes

397 (37.3%)

264 (66.5%)

133 (33.5%)

 < 0.001^‡